EBF 11th Open Symposium: Raise the Anchor – Set Sail for Science

EBF was founded in 2006 at the initiative of 12 pharmaceutical companies, all of them having bioanalytical lab activities in Europe. The goal of bringing these companies together was to implement a platform for discussions of science, day-to-day procedures, business tools, technologies and last but not least regulatory issues. Until 2010, EBF membership was limited to companies involved in bioanalytical activities in a pharmaceutical research and development environment in Europe. From 2011 onwards, the EBF welcomed CROs involved in bioanalytical activities in a pharmaceutical research and development environment in Europe. Currently, the EBF counts 51 members (October 2015). Since 2010, the EBF became a non-profit organisation (vzw) established pursuant to the Belgian Act of 27 June 1921 on non-profit associations, international non-profit associations and foundations.

Open Symposium
Ever since 2008, the EBF organizes a yearly Open Symposium in the 3rd or 4th week of November in Barcelona (Spain). This Open Symposium has become a landmark for bioanalytical discussions in EU and has created a true Forum-like spirit where people meet and open discussions during sessions and presentations contribute to the development of an open mind in bioanalysis. For details of the meeting see www.bcn.europeanbioanalysisforum.eu.

2018 program
View the 11th EBF Open Symposium program here.

Highlights from our Partners

  • During the 11th EBF Open Symposium, Intertek Pharmaceutical Services will be presenting a poster at Booth B26

    Comparison of Drug Tolerance and Sensitivity for a Monoclonal Antibody across ADA Formats
    Authors: Anthony Upton, Laboratory Director Bioanalysis, Jeff Beauchaine, Team Leader, Immunoassays

    Intertek experts will also co-facilitate Workshop 3 at 2pm Day 1 of the 11th EBF Open Symposium
    WS 3: Exploratory Biomarker Validation. Contact bioanalysis@intertek.com for more information.

  • At EBF, Shimadzu will promote the following products at Booth C3:

    LCMS-9030 Quadrupole Time-of-Flight Liquid Chromatograph Mass Spectrometer

    Microsampling MSW2

    For more information, click here: https://www.shimadzu.com/opt/products/msw2/o-od0gjn0000008nt8.html


    The inventor Takashi Shimada speaks in the official program: http://bcn.europeanbioanalysisforum.eu/program/ (Day 2-03, 16.20-18.20)

    For more information please find attached and here https://www.shimadzu.eu/nsmol-antibody-ba-kit


    Customized labelled compound with stable isotope: https://www.shimadzu.eu/alsachim

  • At EBF Bio-Rad will be at Booth C2:


    Poster: Drug-Target-Complex Specific Antibodies for Pharmacokinetic Analysis of Biotherapeutics

    Poster: Characterization of Anti-idiotypic Antibodies for High Performance in Bioanalytical Assays

  • Come and see us on Booth 36 at EBF.

    Technial notes

    Universal Solution for Monoclonal Antibody Quantification in Biological Fluids Using Trap-Elute MicroLC-MS Method

    Ultra-Sensitive Quantification of Trastuzumab Emtansine in Mouse Plasma using Trap-Elute MicroLC MS Method


    A High-Throughput Mass Spectrometry Plate-Reader: Acoustic Droplet Ejection to an Open-Port Probe Sampling Interface

    Chang Liu1; Hui Zhang2; Lucien Ghislain3; Jianhua Liu2; Wenyi Hua2; Timothy Foley2; Sammy Datwani3; Don W. Arnold1; Thomas R. Covey1

    1SCIEX; 2Pfizer Global Research and Development.; 3Labcyte

    Highly Selective Bioanalytical Quantitation Method for Analysis of R and S Amlodipine Enantiomers in Human Plasma Using LC-MS/MS

    Rahul Baghla1; Ian Moore1; Sahana Mollah1; Matthew Brusius2; Marc Jacob2

    SCIEX; Phenomenex

    Improved Sensitivity for LC-MS Quantitation of Pharmaceutical Compounds in Human Plasma with MicroLC Using a New Microflow Source Design

    Ian Moore; Carmai Seto; Tom Biesenthal

    Sensitive Quantitation of the ADC Ado-trastuzumab Emtansine Free Cytotoxic Drug DM1 in Serum Using MicroLC-MS

    Remco Van Soest; Khatereh Motamedchaboki; Ian Moore


    Quantitation of Intact Therapeutic Protein in Plasma Matrix by LC/MS

    Yihan Li; Ian Moore; Fan Zhang; Sahana Mollah


    Improved Sensitivity for LC-MS Quantitation of Trastuzumab Emtansine in Rat Plasma with Trap-and-Elute MicroLC Using a New Microflow Source

    Khatereh Motamedchaboki; Remco Van Soest; Ian Moore


    Metabolite Profiling and ID of Cyclic Peptides Using Automated Software Processing and High Resolution Mass Spectrometry

    Jinal Patel; Alina Dindyal-Popescu; Xu Guo; Ian Moore


    SCIEX Solution for Highly Sensitive LC-MS/MS Method for the Quantification of Mometasone Furoate in Human Plasma Using SCIEX QTRAP® 6500 System

    M Chandrasekar; Aman Sharma; Anoop Kumar; Dilip Reddy; Manoj Pillai; Ian Moore

    SCIEX India; SCIEX

  • Visit Waters at Booth B16 to chat to our specialists, and enter our raffle for a chance to win access to the Exclusive Bioanalysis Zone party on November 22nd. Waters @ EBF!

    Waters to introduce an automated sample preparation workflow for Hybrid LC-MS/MS Protein Quantification at EBF

    Developing and running highly sensitive and accurate LC-MS/MS assays for large molecule quantification can prove to be quite challenging and time consuming.

    This year at EBF, Dr. Ian J. Edwards from Waters will present the proof of concept of a fully automated sample preparation workflow for mAb quantification from serum/plasma.

    Join Dr. Edwards on Friday, November 23rd at 10 a.m. in the Auditorium, and uncover a more simplified and standardised approach that is automated to streamline the sample preparation workflow, reduce variability and increase lab productivity.

 Event Details 

Start Date
Nov 21, 2018
End Date
Nov 23, 2018
NH Collection Tower, Barcelona, Spain,